A new nasal spray form of the medication bumetanide may reduce the tissue swelling caused by heart failure as effectively as ...

An anti-Alzheimer's nasal spray that could delay the progress of the disease by years has been developed by scientists at ...

FluMist, the nasal flu vaccine spray, was approved in September by the U.S. Food and Drug Administration for at-home use starting in fall 2025. Currently, it can only be administered by a healthcare ...

Researchers have developed a promising nasal spray therapy targeting neuroinflammation in Alzheimer’s disease, potentially ...